TNF and hematologic disorder: We thus further subdivided the ImCo patients into two groups partly based on immunosuppression: Solid organ transplantation (SOT) and other immunosuppression (Other ImSupp) including the patients on anti-CD20 treatment, hematological malignities and TNF-α inhibitory treatment.